您的购物车当前为空
别名 BZAD-01, BZAD 01
BZAD01 是一种选择性 NMDA NR1A/2B 受体拮抗剂。


为众多的药物研发团队赋能,
让新药发现更简单!
BZAD01 是一种选择性 NMDA NR1A/2B 受体拮抗剂。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 138 | 现货 | |
| 5 mg | ¥ 330 | 现货 | |
| 10 mg | ¥ 538 | 现货 | |
| 25 mg | ¥ 1,070 | 现货 | |
| 50 mg | ¥ 1,660 | 现货 | |
| 100 mg | ¥ 2,450 | 现货 | |
| 200 mg | ¥ 3,310 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 441 | 现货 |
BZAD01 相关产品
| 产品描述 | BZAD01 is a selective NMDA NR1A/2B receptor antagonist. |
| 体内活性 | Parkinsonism was induced by microinjection of the toxin, 6-hydroxydopamine (6-OHDA) into the medial forebrain bundle (MFB) of 40 Sprague-Dawley rats. Parkinsonism and the efficacy of drugs were assessed using a battery of behavioural tests including balance beam, apomorphine-induced rotation, body axis bias or "curling", head position bias and disengage sensorimotor latency test. The main effects were that BZAD01 co-administration prevented chronic levodopa-induced potentiation of apomorphine rotation. However levodopa-treated rats were slower than either controls or BZAD-01-treated rats in the locomotor test[2]. |
| 别名 | BZAD-01, BZAD 01 |
| 分子量 | 362.27 |
| 分子式 | C16H12F6N2O |
| CAS No. | 305339-41-7 |
| Smiles | FC(F)(F)Oc1ccc(cc1)C(=N)NCc1ccccc1C(F)(F)F |
| 密度 | 1.34 g/cm3 (Predicted) |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 55 mg/mL (151.82 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容